Material Agreements

Silexion Therapeutics Corp entered into Inducement Letter with certain holders valued at approximately $1.0 million (effective 2026-05-15).

“On May 15, 2026, Silexion Therapeutics Corp (“ Silexion ” or the “ Company ”) entered into an inducement offer letter agreement (the “ Inducement Letter ”) with certain holders (each a “ Holder ”) of 1,995,092 of the Company’s existing warrants”

Crypto Co entered into Subscription Agreements with Boulder Syndicate Ltd and Ron Levy valued at $55,000 (effective 2026-05-11).

“On May 11, 2026, The Crypto Company (the “ Company ”) executed Subscription Agreements (each, a “ Subscription Agreement ” and collectively, the “ Subscription Agreements ”) with certain institutional and other accredited investors: Boulder Syndicate Ltd and Ron Levy (each, an “ Investor ” and collectively, the “ Investors ”), pursuant to which the Company agreed to sell and issue to the Investors an aggregate of 17,600,000 shares of the Company’s common stock, par value $0.001 (“ Common Stock ”) for an aggregate purchase price of $55,000 in cash, in a private placement transaction”

Playboy, Inc. entered into Additional Lease with RK Rivani LLC valued at Lease of rest of floor; term from May 1, 2026 to Nov 30, 2037 with two five-year renewal options; ba (effective 2026-05-01).

“On May 14, 2026, PEI also entered into a new lease agreement (the “Additional Lease”) with the Landlord, pursuant to which, among other matters and on the terms and subject to the conditions set forth in the Additional Lease, PEI will lease the rest of the floor of the building not already part of the Premises, such that, with the Original Lease (as amended) and the Additional Lease, PEI has rented the entire floor of the building for use as the office of the Company and its subsidiaries.”

Playboy, Inc. amended Lease Amendment with RK Rivani LLC valued at Amendment changes delivery/term commencement to Jan 1, 2027; expiration to Nov 30, 2037; abates rent (effective 2026-05-14).

“On May 14, 2026, Playboy Enterprises, Inc. (“PEI”), a Delaware corporation and a wholly-owned subsidiary of Playboy, Inc. (the “Company”), entered into an Amendment to Lease Agreement (the “Lease Amendment”) with RK Rivani LLC, a Florida limited liability company (the “Landlord”), which amends that certain lease agreement entered into by PEI and the Landlord, on August 11, 2025 (the “Original Lease”), for the rental of office space comprising most of an entire floor (the “Premises”) of a building in Miami Beach.”

Brag House Holdings, Inc. amended Amendment No. 4 to the Merger Agreement with House of Doge Inc. (effective 2026-05-11).

“On May 11, 2026, the parties entered into Amendment No. 4 to the Merger Agreement (the “ Amendment ”). The Amendment extends the date after which either the Company or House of Doge can terminate the Merger Agreement if the transactions contemplated thereby have not been consummated to June 30, 2026.”

Breeze Acquisition Corp. II entered into Indemnity Agreements with Each officer and director of the Company valued at Indemnification for officers and directors (effective 2026-05-12).

“Indemnity Agreements, each dated May 12, 2026, by and between the Company and each of the officers and directors of the Company”

Breeze Acquisition Corp. II entered into Private Placement Units Purchase Agreement with Breeze Sponsor II, LLC valued at Private placement of units to sponsor (effective 2026-05-12).

“● A Letter Agreement, dated May 12, 2026, by and among the Company, Breeze Sponsor II, LLC, IB Capital LLC, and each of the officers and directors of the Company, a copy of which is attached as Exhibit 10.1 hereto and incorporated”

Breeze Acquisition Corp. II entered into Administrative Services Agreement with Breeze Sponsor II, LLC valued at Administrative services provided by sponsor (effective 2026-05-12).

“● A Letter Agreement, dated May 12, 2026, by and among the Company, Breeze Sponsor II, LLC, IB Capital LLC, and each of the officers and directors of the Company, a copy of which is attached as Exhibit 10.1 hereto and incorporated”

Breeze Acquisition Corp. II entered into Registration Rights Agreement with Breeze Sponsor II, LLC, IB Capital LLC valued at Registration rights for shares held by sponsor and underwriter (effective 2026-05-12).

“A Registration Rights Agreement, dated May 12, 2026, by and among the Company, Breeze Sponsor II, LLC, and IB Capital LLC”

Breeze Acquisition Corp. II entered into Investment Management Trust Agreement with Continental Stock Transfer & Trust Company valued at Trust agreement for IPO proceeds (effective 2026-05-12).

“An Investment Management Trust Agreement, dated May 12, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as trustee”

Breeze Acquisition Corp. II entered into Letter Agreement with Breeze Sponsor II, LLC, IB Capital LLC, officers and directors valued at Letter agreement among the Company, sponsor, underwriter, and insiders (effective 2026-05-12).

“A Letter Agreement, dated May 12, 2026, by and among the Company, Breeze Sponsor II, LLC, IB Capital LLC, and each of the officers and directors of the Company”

Breeze Acquisition Corp. II entered into Rights Agreement with Continental Stock Transfer & Trust Company valued at Each Right entitling holder to receive one-fifth of one ordinary share (effective 2026-05-12).

“A Rights Agreement, dated May 12, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as rights agent”

Breeze Acquisition Corp. II entered into Underwriting Agreement with IB Capital LLC valued at Gross proceeds of $125,000,000 from IPO of 12,500,000 units at $10.00 per unit (effective 2026-05-12).

“An Underwriting Agreement, dated May 12, 2026, by and between the Company and IB Capital LLC, as representative of the several underwriters”

MAYS J W INC entered into loan agreement with Beacon Bank & Trust valued at $8,000,000 (effective 2026-05-12).

“On May 12, 2026, J.W. Mays, Inc. (the " Company ") entered into a loan agreement with Beacon Bank & Trust, a Massachusetts Trust Company (the “ Lender ”) wherein the Company has obtained a loan (the “ Loan ”) secured by a first lien mortgage on the Company’s property at Fishkill, New York”

ADVANCED MICRO DEVICES INC terminated Existing Credit Agreement with Wells Fargo Bank, National Association, as administrative agent (effective 2026-05-14).

“In connection with the entry into the Credit Agreement, the Company terminated all remaining commitments of the lenders under the Existing Credit Agreement.”

ADVANCED MICRO DEVICES INC entered into Credit Agreement with lenders named therein, JPMorgan Chase Bank, N.A., as administrative agent valued at $5.0 billion (effective 2026-05-14).

“On May 14, 2026 (the “Closing Date”), Advanced Micro Devices, Inc. (the “Company”) entered into a Credit Agreement with the lenders named therein, JPMorgan Chase Bank, N.A., as administrative agent, and the other parties from time to time party thereto (the “Credit Agreement”).”

ServiceNow, Inc. entered into Indenture and Underwriting Agreement with U.S. Bank Trust Company, National Association valued at $4,000,000,000 aggregate principal amount of notes (effective 2026-05-15).

“On May 15, 2026, ServiceNow, Inc. (the “ Company ”) completed an offering of $4,000,000,000 aggregate principal amount of notes, consisting of $750,000,000 aggregate principal amount of its 4.250% Notes due 2028 (the “ 2028 Notes ”), $600,000,000 aggregate principal amount of its 4.700% Notes due 2031 (the “ 2031 Notes ”), $650,000,000 aggregate principal amount of its 5.050% Notes due 2033 (the “ 2033 Notes ”), $1,250,000,000 aggregate principal amount of its 5.400% Notes due 2036 (the “ 2036 Notes ”), and $750,000,000 aggregate principal amount of its 6.300% Notes due 2056 (the “ 2056 Notes ” and, together with the 2028 Notes, the 2031 Notes, the 2033 Notes, and the 2036 Notes, the “ Notes ”).”

BranchOut Food Inc. entered into Second Amended and Restated Secured Promissory Note with Kaufman Kapital LLC valued at $750,000 additional borrowing under Second Amended and Restated Secured Promissory Note in principal (effective 2026-05-15).

“On May 15, 2026, the Company borrowed an additional $750,000 from Kaufman on the same terms provided for under the Note (the “Additional Loan”), pursuant to a Second Amended and Restated Secured Promissory Note in the principal amount of $3,000,000 (the “Note”), which amends and restates the Note.”

BranchOut Food Inc. amended 12% Senior Secured Convertible Promissory Note with Kaufman Kapital LLC valued at Added 9.99% beneficial ownership limitation provision (effective 2026-05-14).

“On May 14, 2026, BranchOut Food Inc. (the “Company”), and Kaufman Kapital LLC (“Kaufman”), entered into an amendment to the 12% Senior Secured Convertible Promissory Note of the Company in the original principal amount of up to $3,400,000, dated as of July 23, 2024 (the “Convertible Note”), pursuant to which a 9.99% beneficial ownership limitation provision was added to the Convertible Note.”

NATIONAL HEALTHCARE CORP entered into Purchase and Sale Agreement with National Health Corporation valued at $50.5 million (effective 2026-05-14).

“On May 14, 2026 (the “Effective Date”), NHC/OP, L.P., a Delaware limited partnership (“Buyer”) and a wholly-owned subsidiary of National HealthCare Corporation (“NHC”), entered into a Purchase and Sale Agreement (the “Agreement”) with National Health Corporation, a Tennessee corporation (“Seller”), to purchase from Seller the land, buildings, and other specified assets of Seller’s portfolio of five skilled nursing facilities”

Glimpse Group, Inc. entered into Securities Purchase Agreement with certain investors valued at approximately $1.79 million (effective 2026-05-14).

“On May 14, 2026, The Glimpse Group, Inc. (the “Company”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) with certain investors (the “Investors”), pursuant to which the Company agreed to sell and issue to the Investors, in a registered direct offering (the “Offering”), (i) 622,306 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), together with accompanying warrants to purchase up to 4,193,182 shares of Common Stock (with each accompanying warrant exercisable for one and one-quarter shares of Common Stock) (the “Common Stock Warrants”), and (ii) in lieu of Common Stock to certain of the Investors, pre-funded warrants to purchase up to 2,732,240 shares of Common Stock (the “Pre-Funded Warrants”).”

CDT Equity Inc. entered into second amendment to directed stock purchase agreement with an institutional investor valued at gross purchase price $510,000; 90% of proceeds retained by Company; effective through May 31, 2026 (effective 2026-05-15).

“On May 15, 2026, CDT Equity Inc. (the “Company”) entered into the second amendment (the “Amendment No. 2”) to that certain directed stock purchase agreement, dated January 16, 2026 (as amended, the “Purchase Agreement”), with an institutional investor (the “Purchaser”) relating to an equity line of credit facility (the “ELOC”).”

Israel Acquisitions Corp amended Fifth BCA Amendment with Gadfin Ltd. and Gadfin Regev Holdings Ltd. (effective 2026-05-15).

“On May 15, 2026, the Company, Gadfin, and Gadfin Regev Holdings Ltd., a company domiciled in Israel entered into a fifth amendment to the BCA (the “ Fifth BCA Amendment ”).”

ARTELO BIOSCIENCES, INC. terminated Sales Agreement with R.F. Lafferty & Co., Inc. valued at up to $6,500,000 (effective 2026-05-18).

“On May 11, 2026, Artelo Biosciences, Inc. (the “Company”) provided notice to R.F. Lafferty & Co., Inc. (“R.F. Lafferty”) of its election to terminate that certain At-The-Market Offering Agreement, dated July 18, 2025, by and between the Company and R.F. Lafferty (the “Sales Agreement”), which termination will be effective on May 18, 2026, in accordance with the terms of the Sales Agreement.”

Encompass Health Corp entered into Purchase Agreement with Wells Fargo Securities, LLC, as the representative of the initial purchasers valued at $500,000,000 in aggregate principal amount of 5.875% senior notes due 2034 (effective 2026-05-14).

“On May 14, 2026, Encompass Health Corporation (the “Company”) and certain of its subsidiaries, as guarantors (the “Guarantors”), entered into a purchase agreement (the “Purchase Agreement”) with Wells Fargo Securities, LLC, as the representative of the initial purchasers (the “Initial Purchasers”), with respect to a private offering (the “Notes Offering”) by the Company of $500,000,000 in aggregate principal amount of 5.875% senior notes due 2034 (the “Notes”), along with the related guarantees of the Notes.”

HILLS BANCORPORATION entered into Agreement of Purchase and Sale with not explicitly named (the Seller) valued at $20,700,000 (effective 2026-05-11).

“On May 11, 2026, Hills Bank and Trust Company ("Hills Bank"), a wholly-owned subsidiary of Hills Bancorporation (the "Company"), entered into an Agreement of Purchase and Sale (the "Agreement") for the acquisition of land and improvements consisting of approximately 19.2 acres, which is a portion of land commonly known as 200 and 500 ACT Drive, Iowa City, Iowa.”

SLM Corp entered into Supplemental Indenture with Deutsche Bank National Trust Company valued at $500,000,000 aggregate principal amount (effective 2026-05-15).

“On May 15, 2026, SLM Corporation (the “Company”) closed an offering of $500,000,000 aggregate principal amount of 6.495% Fixed-to-Floating Rate Senior Notes due 2032 (the “Notes”) issued by the Company (the “Offering”).”

Enhabit, Inc. entered into First Amendment to Amended and Restated Credit Agreement with Wells Fargo Bank, National Association valued at $105,000,000 incremental term loans and $40,000,000 revolving credit commitment increase (effective 2026-05-15).

“On May 15, 2026, Parent, Merger Sub, the Company and certain of its subsidiaries entered into a First Amendment to Amended and Restated Credit Agreement (the “ First Amendment ”) with the lenders party thereto and Wells Fargo Bank, National Association, as administrative agent for the lenders (in such capacity, the “ Administrative Agent ”) and as collateral agent for the lenders (in such capacity, the “ Collateral Agent ”), which amends that certain Amended and Restated Credit Agreement, dated as of February 26, 2026 (as amended, restated, amended and restated, supplemented or otherwise modified from time to time and as amended by the First Amendment, the “ Credit Agreement ”), by and among the Company, the financial institutions party thereto as lenders, swingline lenders and issuing banks, the Administrative Agent and the Collateral Agent.”

CSB Financial Inc. entered into Agency Agreement with Performance Trust Capital Partners, LLC (effective 2026-05-14).

“On May 14, 2026, CSB Financial Inc. (the “Company”) and Community Savings Bank (the “Bank”) entered into an Agency Agreement with Performance Trust Capital Partners, LLC”

Columbia Financial, Inc. entered into Agency Agreement with Keefe Bruyette & Woods, Inc..

“Columbia Bank, MHC and Columbia Bank entered into an Agency Agreement with Keefe Bruyette & Woods, Inc. (“KBW”), which will assist the Company on a best efforts basis in selling the shares of the Company’s common stock in the Company’s subscription and community offerings, and act as lead-left book running manager for any firm commitment underwritten offering.”

Quartzsea Acquisition Corp entered into Agreement and Plan of Merger with Eight Directions Technology Limited, Jeffrey & Vans Technology Inc., Pivot Technology Holding Inc., Chengji Zhang, Eight Directions Global Limited, CUPS Sub Limited (effective 2026-05-13).

“ntative”), Eight Directions Global Limited, a Cayman Islands exempted company and wholly owned subsidiary of Parent (“Purchaser”), and CUPS Sub Limited, a Cayman Islands exempted company and wholly owned subsidiary of Purchaser (“Merger Sub”), entered into an Agreement and Plan of Merger (the “Merger Agreement”). Capitalized terms used herein but not otherwise defined herein have the meanings ascribed to them in the Merger Agreement.”

TPG RE Finance Trust, Inc. entered into Credit Agreement with Wells Fargo Bank, N.A., as administrative agent and collateral agent, and certain other lenders and issuing banks valued at term loans in an aggregate principal amount of $400,000,000 and a revolving credit facility in an ag (effective 2026-05-14).

“On May 14, 2026 (the “Closing Date”), TPG RE Finance Trust, Inc. (the “Company”), as borrower, entered into a Credit Agreement (the “Credit Agreement”) with Wells Fargo Bank, N.A. (“Wells Fargo”), as administrative agent and collateral agent (in such capacities, the “Agent”), and certain other lenders and issuing banks named therein.”

G III APPAREL GROUP LTD /DE/ entered into License Agreement with IPCo, G-III Leather Fashions, Inc., G-III Apparel Canada, ULC valued at exclusive license to use Marc Jacobs brands and related IP; initial term through December 2041.

“At Closing, IPCo, G-III Leather Fashions, Inc. and G-III Apparel Canada, ULC (together with G-III Leather Fashions, Inc., the "Licensee"), will enter into a License Agreement (the "License Agreement"), pursuant to which IPCo will provide an exclusive license to the Licensee to use the Marc Jacobs brands and related intellectual property held by IPCo, as well as certain other intellectual property rights developed in the future (collectively, the "Licensed IP") in the United States, Canada, Mexico and Western Europe for the operation of Marc Jacobs-branded retail stores and branded e-commerce sites and the distribution, sale and promotion of specified categories of products, including women's and men's apparel, handbags, footwear, swim, small leather goods, luggage and cold weather accessories (through wholesale, branded retail stores and branded e-commerce sites).”

G III APPAREL GROUP LTD /DE/ entered into Transition Services Agreement with Marc Jacobs International, LVMH, Purchaser, Purchaser Parent, Company valued at transition services following Closing.

“At Closing, Marc Jacobs International, L.L.C. ("Marc Jacobs International"), LVMH and, solely for guaranty purposes, Purchaser, Purchaser Parent and the Company will enter into a Transition Services Agreement (the "TSA"), pursuant to which, following Closing, LVMH and/or third-party providers will provide certain transition services to Marc Jacobs International and its subsidiaries.”

G III APPAREL GROUP LTD /DE/ entered into Interim Investors' Agreement with IPCo, Purchaser, MJWHP, LLC, WHP Member, Purchaser Parent valued at governs relationship between Company and WHP Member until Closing.

“On the Signing Date, IPCo, Purchaser, MJWHP, LLC, a Delaware limited liability company ("WHP Member"), the Company and Purchaser Parent entered into an Interim Investors' Agreement (the "Interim Investors' Agreement") which will govern the relationship between the Company and the WHP Member until the Closing.”

G III APPAREL GROUP LTD /DE/ entered into Equity Commitment Letter with IPCo valued at aggregate amount equal to the sum of WHP's equity contribution.

“The Company will operate the business pursuant to a license from IPCo. Item 1.01 Entry into a Material Definitive Agreement Unit Purchase Agreement On the Signing Date, Purchaser”

G III APPAREL GROUP LTD /DE/ entered into Unit Purchase Agreement with owners of all of the issued and outstanding units of Marc Jacobs Holdings, LLC and WH Borrower, LLC valued at approximately $500 million investment.

“On the Signing Date, Purchaser entered into a Unit Purchase Agreement (the "Unit Purchase Agreement") with the owners of all of the issued and outstanding units of Marc Jacobs Holdings, LLC (together, the "Sellers") and, solely for specified sections, WH Borrower, LLC ("Purchaser Parent"), pursuant to which Purchaser agreed to purchase from Sellers all of the issued and outstanding common units of Marc Jacobs Holdings, LLC (the "Acquisition").”

Lantern Pharma Inc. entered into Purchase Agreement with institutional investors valued at approximately $4.4 million (effective 2026-05-12).

“On May 12, 2026, Lantern Pharma Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with institutional investors”

Pacific Oak Strategic Opportunity REIT, Inc. entered into Loan Agreement with KM PORT US Financing US LP, PORT 2026-04 Lender, LLC and other co-lenders valued at up to $216 million (effective 2026-05-08).

“On May 8, 2026, Reven Housing Funding 1, LLC, Reven Housing Funding 2, LLC, BPDM Properties 2018-1 LLC and PORTII Properties 2020-1 LLC (together, the “Borrowers”) and Pacific Oak Residential Trust Inc. (“PORT”), entered into a loan agreement (the “Loan Agreement”) with KM PORT US Financing US LP, PORT 2026-04 Lender, LLC and other co-lenders (collectively, the “Lenders”) as lenders and KM PORT US Financing US LP (“Administrative Agent”), as administrative agent.”

Polar Power, Inc. entered into Revolving Loan Agreement with Stone Brothers Capital valued at $2,500,000 (effective 2026-05-13).

“On May 13, 2026, Polar Power, Inc. (the “Company”) entered into a Revolving Loan Agreement (the “Loan Agreement”) with Stone Brothers Capital (the “Lender”). The Loan Agreement provides for a revolving credit facility under which the Lender may, in its sole discretion upon the request of the Company, make loans (the “Loans”) to the Company, in an aggregate principal amount at any one time outstanding not to exceed $2,500,000.”

CSG SYSTEMS INTERNATIONAL INC terminated Existing Credit Agreement with Royal Bank of Canada, as administrative agent, collateral agent, swingline lender and an issuing bank valued at $125 million (effective 2026-05-14).

“on May 14, 2026, all outstanding indebtedness and other amounts outstanding and owed under that certain Credit Agreement (the “Existing Credit Agreement”), dated as of March 14, 2025, by and among CSG, as borrower, its subsidiary guarantors party thereto, Royal Bank of Canada, as administrative agent, collateral agent, swingline lender and an issuing bank (“RBC”), Citizens Bank, N.A. and PNC Bank, National Association, as co-documentation agents, the lenders party thereto and the other issuing banks party thereto, was repaid in full and all commitments thereunder were terminated”

CEL SCI CORP entered into a license with Amarox.

“the Company issued a press release, filed as Exhibit 99, concerning a strategic partnership, distribution, and revenue sharing agreement with Amarox for regulatory affairs, marketing and potential commercialization of Multikine (Leukocyte Interleukin, Injection) in the treatment of head and neck cancer in Saudi Arabia, with an optional extension for the Gulf Cooperation Council (GCC) countries including Bahrain, Kuwait, Oman, Qatar, and the United Arab Emirates.”

Rhinebeck Bancorp, Inc. entered into Agency Agreement with Keefe, Bruyette & Woods, Inc. (effective 2026-05-14).

“On May 14, 2026, Rhinebeck Bancorp, MHC (the “MHC”), the parent mutual holding company of Rhinebeck Bancorp, Inc. (the “Company”), the Company, and Rhinebeck Bank, the Company’s wholly owned subsidiary, entered into an Agency Agreement with Keefe, Bruyette & Woods, Inc. (“KBW"), which will assist in the marketing of the Company’s common stock during its stock offering.”

TYLER TECHNOLOGIES INC entered into Indenture with U.S. Bank Trust Company, National Association valued at $1,437,500,000 aggregate principal amount (effective 2026-05-14).

“On May 14, 2026, Tyler Technologies, Inc. (the “Company”) issued $1,437,500,000 aggregate principal amount of its 0.50% Convertible Senior Notes due 2031 (the “Notes”). The Notes were issued pursuant to, and are governed by, an indenture (the “Indenture”), dated as of May 14, 2026, between the Company and U.S. Bank Trust Company, National Association, as trustee”

Vivakor, Inc. entered into Standby Equity Purchase Agreement with one of the Investors valued at up to $100,000,000 (effective 2026-05-07).

“on May 7, 2026, the Company entered into a standby equity purchase agreement (the “SEPA”) with one of the Investors (the “SEPA Investor”), under which the SEPA Investor has committed to purchase from the Company up to $100,000,000 of shares of the Company’s common stock in an equity line of credit (the “Equity Line")”

Vivakor, Inc. entered into Securities Purchase Agreement with certain institutional investors valued at up to $12.0 million (effective 2026-05-08).

“On May 8, 2026, Vivakor, Inc. (the “Company”) closed the first tranche of a transaction with certain institutional investors (the “Investors”) under the terms of a Securities Purchase Agreement (the “SPA”) to issue and sell to each of the Investors promissory notes (the “Notes”), for aggregate gross proceeds to the Company of up to $12.0 million (the “ Purchase Price")”

GREIF, INC terminated Third Amended and Restated Transfer and Administration Agreement with Bank of America, N.A. (effective 2026-05-11).

“On May 11, 2026, the obligations outstanding under the Existing TAA were satisfied by the assignment to and assumption of such obligations by the Receivables Facility, and the Existing TAA was terminated as of that date.”

GREIF, INC amended Fourth Amended and Restated Transfer and Administration Agreement with PNC Bank, National Association valued at $200 million (effective 2026-05-11).

“On May 11, 2026, certain U.S. subsidiaries of Greif, Inc. (the “Company”) amended and restated the existing receivables financing facility (the “Receivables Facility”). Greif Receivables Funding LLC (“Greif Funding”), Greif Packaging LLC (“Greif Packaging”), for itself and as servicer, and certain other U.S. subsidiaries of the Company entered into a Fourth Amended and Restated Transfer and Administration Agreement, dated as of May 11, 2026 (the “Fourth Amended TAA”), with PNC Bank, National Association (“PNC”), as the agent, managing agent, administrator and committed investor, and various investor groups, managing agents, and administrators, from time to time parties thereto.”

Lifeway Foods, Inc. entered into Underwriting Agreement with BTIG, LLC and Danone USA Public Benefit Corporation (effective 2026-05-14).

“On May 14, 2026, Lifeway Foods, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with BTIG, LLC (the “Underwriter”) and Danone USA Public Benefit Corporation (the “Selling Stockholder”) in connection with a public offering of an aggregate of 3,454,756 shares (the “Shares”) of the Company’s common stock, no par value (the “Common Stock”), by the Selling Stockholder at a price to the public of $19.50 per share (the “Offering”).”

MAIA Biotechnology, Inc. terminated At The Market Offering Agreement with H.C. Wainwright & Co., LLC (effective 2026-05-14).

“On May 14, 2026, MAIA Biotechnology, Inc. (the “Company”) suspended sales of its common stock, par value $0.0001 per share (“Common Stock”), pursuant to that certain At The Market Offering Agreement dated February 14, 2024, or the sales agreement, between the Company and H.C. Wainwright & Co., LLC (the “Agent”), the Company’s sales agent thereunder, and provided notice to the Agent that it is terminating the sales agreement, which termination will be effective 7-business days after May 14, 2026, in accordance with the terms of the sales agreement.”